QuidelOrtho Corp (QDEL) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 38 days, typically, give or take 4 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Tue, Nov 3, 2026after close 37 8-K
Q2 FY2026Thu, Aug 6, 2026after close 39 8-K
Q1 FY2026Tue, May 5, 2026after close 37 8-K
Q4 FY2025Wed, Feb 11, 2026after close 45 8-K
Q3 FY2025Wed, Nov 5, 2025after close 38 8-K
Q2 FY2025Tue, Aug 5, 2025after close 37 8-K
Q1 FY2025Wed, May 7, 2025after close 38 8-K
Q4 FY2024Wed, Feb 12, 2025after close 45 8-K

What they guided beta

Q3 FY2026 "Document Exhibit 99.1 QuidelOrtho Reports Third Quarter 2026 Financial Results ― Growth in Labs and Immunohematology Outside of China Highlights Underlying Business Strength ― ― New Cost Transformation and Enterprise Restructuring Program Expected to Deliver Over $80 Million in Annual Savings in 2027 ― ― Updated Full-Year 2026 Financial Guidance Narrowing Prior Ranges ― November 3, 2026 SAN DIEGO, CA November 3, 2026 — QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a leading global provider of diagnostic solutions, today announced financial results for the third quart" exhibit
Q3 FY2026 "The Company expects the program to deliver over $80 million in annual savings in 2027 and to record approximately $30 to $35 million in one-time restructuring charges in the fourth quarter of 2026." exhibit
Q3 FY2026 "Full-year 2026 Financial Guidance Based on its current business outlook, the Company is updating its full-year financial guidance below: Full-year 2026 Financial Guidance As of 11/3/2026 As of 8/6/2026 Total revenues (reported) $2.52 - $2.54 billion $2.52 - $2.60 billion Adjusted EBITDA $540 - $545 million $540 - $560 million Adjusted EBITDA margin ~21% 21% - 22% Adjusted diluted EPS $0.65 - $0.70 $0.65 - $0.90 Please see page 8 of the Third Quarter 2026 Financial Results presentation on the “Investor Relations” page of the Company’s website for the full list of assumptions on which the Compan" exhibit
Q3 FY2026 "These statements are any statement contained herein that is not strictly historical, including, but not limited to, QuidelOrtho’s commercial and other strategic goals, financial guidance for 2026 and related assumptions and other future financial condition and operating results, including growth expectations and expected results of operations, financial position or cost-savings and operational improvement initiatives, including the expected results and anticipated benefits of the cost transformation and enterprise restructuring program and the timing and amount of related charges, and other fu" exhibit
Q2 FY2026 "Document Exhibit 99.1 QuidelOrtho Reports Second Quarter 2026 Financial Results ― Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth― ― Excluding China, total revenue grew 6% both as reported and in constant currency ― ― Company updates full-year 2026 financial guidance ― August 6, 2026 SAN DIEGO, CA August 6, 2026 — QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a leading global provider of diagnostic solutions, today announced financial results for the second quarter ended June 28, 2026." exhibit
Q2 FY2026 "“As a result, we are revising our full-year 2026 revenue and earnings guidance to reflect these evolving market dynamics." exhibit
Q2 FY2026 "Full-year 2026 Financial Guidance Based on its current business outlook, the Company is updating its full-year financial guidance below: Full-year 2026 Financial Guidance Updated (as of 8/6/2026) Previous (as of 5/5/2026) Total revenues (reported) $2.52 - $2.60 billion $2.70 - $2.75 billion Adjusted EBITDA $540 - $560 million $615 - $630 million Adjusted EBITDA margin 21% - 22% 23% Adjusted diluted EPS $0.65 - $0.90 $1.80 - $2.00 Free cash flow Withdrawn $100 - $120 million Please see page 8 of the Second Quarter 2026 Financial Results presentation on the “Investor Relations” page of the Compa" exhibit
Q2 FY2026 "These statements are any statement contained herein that is not strictly historical, including, but not limited to, QuidelOrtho’s commercial and other strategic goals, financial guidance for 2026 and related assumptions and other future financial condition and operating results, including growth expectations and expected results of operations, financial position or cost-savings and operational improvement initiatives, and other future plans, objectives, strategies, expectations and intentions." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/QDEL
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/QDEL

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

QDEL earnings date badge

HTML

<a href="https://veritasdata.dev/company/QDEL/"><img src="https://veritasdata.dev/embed/QDEL.svg" alt="QDEL earnings date" width="240" height="56"></a>

Markdown

[![QDEL earnings date](https://veritasdata.dev/embed/QDEL.svg)](https://veritasdata.dev/company/QDEL/)

Script

<script async src="https://veritasdata.dev/embed/QDEL.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/QDEL"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.